Exciton Technologies Inc.

Published purpose

Recent global events have shed light on the vulnerabilities within our health care systems. The growing threat of antimicrobial resistance is hailed as a pandemic in the making. As the antibiotics drug development pipeline dwindles, effective solutions to combat antimicrobial resistant strains of pathogenic bacteria are urgently needed. ETI has successfully developed a silver-oxygen scaffold gel device for the effective eradication of biofilm and pathogenic bacterium, including resistant clinical isolates, while facilitating wound healing. Employing a multidisciplinary team, this project will facilitate large scale production and distribution of this disruptive device to capture market share and combat resistance.